Positron emission tomography agent 2-deoxy-2-[(18)F]fluoro-D-glucose has a therapeutic potential in breast cancer

BACKGROUND: Novel approaches are needed for breast cancer patients in whom standard therapy is not effective. 2-Deoxy-2-[(18)F]fluoro-D-glucose ((18)F-FDG) was evaluated as a potential radiomolecular therapy agent in breast cancer animal models and, retrospectively, in patients with metastatic breas...

Descripción completa

Detalles Bibliográficos
Autores principales: Moadel, Renee M, Nguyen, Andrew V, Lin, Elaine Y, Lu, Ping, Mani, Joseph, Blaufox, M Donald, Pollard, Jeffrey W, Dadachova, Ekaterina
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2003
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC314404/
https://www.ncbi.nlm.nih.gov/pubmed/14580255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC314404/
https://www.ncbi.nlm.nih.gov/pubmed/14580255

Ejemplares similares